Emergent BioSolutions, Inc. (EBS)
5.18
+0.10
(+1.97%)
USD |
NYSE |
Aug 24, 16:00
5.20
+0.02
(+0.39%)
Pre-Market: 05:56
Emergent BioSolutions Market Cap : 265.73M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 265.73M |
| August 21, 2026 | 260.60M |
| August 20, 2026 | 247.27M |
| August 19, 2026 | 250.86M |
| August 18, 2026 | 239.06M |
| August 17, 2026 | 230.85M |
| August 14, 2026 | 235.47M |
| August 13, 2026 | 230.34M |
| August 12, 2026 | 233.42M |
| August 11, 2026 | 228.28M |
| August 10, 2026 | 229.31M |
| August 07, 2026 | 248.29M |
| August 06, 2026 | 272.40M |
| August 05, 2026 | 386.80M |
| August 04, 2026 | 388.34M |
| August 03, 2026 | 379.39M |
| July 31, 2026 | 374.00M |
| July 30, 2026 | 376.07M |
| July 29, 2026 | 380.73M |
| July 28, 2026 | 378.66M |
| July 27, 2026 | 379.69M |
| July 24, 2026 | 376.07M |
| July 23, 2026 | 388.50M |
| July 22, 2026 | 392.64M |
| July 21, 2026 | 396.27M |
| Date | Value |
|---|---|
| July 20, 2026 | 398.34M |
| July 17, 2026 | 395.23M |
| July 16, 2026 | 398.34M |
| July 15, 2026 | 408.70M |
| July 14, 2026 | 388.50M |
| July 13, 2026 | 414.92M |
| July 10, 2026 | 416.99M |
| July 09, 2026 | 423.72M |
| July 08, 2026 | 421.65M |
| July 07, 2026 | 429.42M |
| July 06, 2026 | 423.72M |
| July 02, 2026 | 428.90M |
| July 01, 2026 | 428.90M |
| June 30, 2026 | 434.08M |
| June 29, 2026 | 438.23M |
| June 26, 2026 | 441.85M |
| June 25, 2026 | 413.36M |
| June 24, 2026 | 436.67M |
| June 23, 2026 | 414.92M |
| June 22, 2026 | 406.63M |
| June 18, 2026 | 414.40M |
| June 17, 2026 | 421.65M |
| June 16, 2026 | 401.45M |
| June 15, 2026 | 429.42M |
| June 12, 2026 | 430.98M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Exelixis, Inc. | 13.58B |
| Capricor Therapeutics, Inc. | 395.14M |
| ADMA Biologics, Inc. | 2.152B |
| Akebia Therapeutics, Inc. | 244.73M |
| Arcutis Biotherapeutics, Inc. | 3.112B |
Market Cap Related Metrics
| PS Ratio | 0.3649 |
| Price to Book Value | 0.7784 |
| Price to Free Cash Flow | 3.271 |
| Price | 5.18 |
| Earnings Yield | -68.60% |
| Operating PE Ratio | 2.053 |